Position in AZN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$170,394,135
New position
Shares Held
863,980
first reported quarter
Ownership
0.056%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MUFG Securities EMEA plc holds $423,932,325 across 10 Drug Manufacturers - General names. AZN ranks #1 (40.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
863,980 | $170,394,135 | |
| 2 | ABBV |
AbbVie Inc.
|
432,445 | $94,052,463 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
521,862 | $72,731,906 | |
| 4 | LLY |
ELI LILLY & Co
|
32,487 | $29,880,567 | |
| 5 | JNJ |
Johnson & Johnson
|
98,798 | $24,150,183 | |
| 6 | MRK |
Merck & Co., Inc.
|
101,752 | $12,239,748 | |
| 7 | AMGN |
Amgen Inc
|
22,085 | $7,770,607 | |
| 8 | PFE |
Pfizer Inc
|
233,159 | $6,547,104 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $170,394,135 | 863,980 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||